Akebia Therapeutics (AKBA) Other Working Capital Changes (2013 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Other Working Capital Changes of $1.8 million for Q1 2026, up 238.55% year-over-year from $536110.5 in Q1 2025, and up 132.11% quarter-over-quarter from -$5.7 million in Q4 2025.
Akebia Therapeutics (AKBA) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Other Working Capital Changes for 9 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 238.55% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at -$2.3 million (up 55.15% YoY), while the FY2025 annual figure was -$5.4 million, down 20.22% from the prior year.
- Other Working Capital Changes climbed to $1.8 million in Q1 2026 per AKBA's latest filing, from -$5.7 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $8.7 million in Q4 2022 and bottomed at -$9.2 million in Q3 2022.
- Historically, Other Working Capital Changes has averaged -$1.7 million across 5 years, with a median of -$1.8 million in 2023.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes sank 2885.87% — and 2025, when it jumped 349.07%.
- Akebia Therapeutics' Other Working Capital Changes stood at $506000.0 in 2022, then slumped by 1447.63% to -$6.8 million in 2023, then soared by 81.24% to -$1.3 million in 2024, then plunged by 341.91% to -$5.7 million in 2025, then soared by 132.11% to $1.8 million in 2026.
- Business Quant data shows AKBA's Other Working Capital Changes at $1.8 million in Q1 2026, -$5.7 million in Q4 2025, and -$5.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Akebia Therapeutics | 248.20 Mn | 92.65 Mn | 38.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.17 Mn |
| Jun 30, 2026 | 2.17 Mn |
| Jun 30, 2026 | 2.17 Mn |
| Mar 31, 2026 | -170,000.00 |
| Mar 31, 2026 | -170,000.00 |
| Mar 31, 2026 | -170,000.00 |
| Dec 31, 2025 | -1.56 Mn |
| Dec 31, 2025 | -1.56 Mn |
| Dec 31, 2025 | -1.56 Mn |
| Sep 30, 2025 | -2.50 Mn |
| Sep 30, 2025 | -2.50 Mn |
| Sep 30, 2025 | -2.50 Mn |
| Jun 30, 2025 | -1.31 Mn |
| Jun 30, 2025 | -1.31 Mn |
| Jun 30, 2025 | -1.31 Mn |
| Mar 31, 2025 | -2.21 Mn |
| Mar 31, 2025 | -2.21 Mn |
| Mar 31, 2025 | -2.21 Mn |
| Dec 31, 2024 | -2.09 Mn |
| Dec 31, 2024 | -2.09 Mn |